Triple-negative breast cancer (TNBC) is an aggressive histological subtype of breast cancer characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and lack of amplification/overexpression of human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to triple-negative breast carcinoma.